← Evidence map

ArticleIndian journal of dermatology

Real-World Indian Experience of Switchover to Bilastine 40 mg/day in CSU Patient Refractory to Other Antihistamines at Double Dose.

Abhishek De et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
trialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38371575